Quantitation and physiological characterization of angiogenic vessels in mice: Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 59-71

  Dellian, Marc ^a   Witwer, Brian P ^a   Salehi, Hassan A ^a   Yuan, Fan ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; ERYTHROCYTE; IMPLANTATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SKINFOLD; SKULL; VELOCITY;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL ADHESION; ENDOTHELIAL GROWTH FACTORS; ERYTHROCYTES; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; LEUKOCYTES; LYMPHOKINES; MALE; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; OBSERVER VARIATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029900738     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
2. Folkman J: Tumor angiogenesis. The Molecular Basis of Cancer. Edited by J Mendelsohn, PM Howley, MA Israel, LA Liotta. Philadelphia, WB Saunders, 1995, pp 206-232
3. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
4. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985
5. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
6. Plate KH, Breier G, Weich H, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-848
7. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo TK, Yeo KT: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584
8. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia up-regulates VEGF expression only. Circulation 1994, 90: 649-652
9. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 1995, 95:1798-1807
10. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994, 79:185-188
11. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995, 55: 510-513
12. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991, 66:1095-1104
13. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR, Fidler IJ: Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 1994, 145:365-374
14. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844
15. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993, 53:5822-5827
16. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995, 95:1789-1797
17. Pötgens AJ, Lubsen NH, van Altena MC, Schoenmakers JG, Ruiter DJ, de Waal RM: Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 1995, 146:197-209
18. Ziche M, Morbidelli L, Alessandri G, Gullino PM: Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab Invest 1992, 67:711-715
19. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 1987, 329:630-632
20. Auerbach R, Auerbach W, Polakowski I: Assays for angiogenesis: a review. Pharmacol Ther 1991, 51:1-11
21. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992, 67:519-528
22. Andrade SP, Fan T-PD, Lewis GP: Quantitative in vivo studies on angiogenesis in a rat sponge model. Br J Exp Pathol 1987, 68:755-766
23. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
24. Axelsson K, Ljung B-ME, Moore DH II, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995, 87:997-1008
25. Nguyen M, Shing Y, Folkman J: Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 1994, 47:31-40
26. Endrich, B, Reinbold, HS, Gross JF, Intaglietta, M: Tissue perfusion inhomogeneity during early tumor growth in rats. J Natl Cancer Inst 1979, 62:387-393
27. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK: Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 1992, 52: 6553-6560
28. Yuan X-Q, Smith TL, Prough DS, De Witt DS, Dusseau JW, Lynch CD, Fulton JM, Hutchins PM: Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. Am J Physiol 1990, 258:H1395-H1401
29. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK: Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994, 54: 4564-4568
30. Yuan F, Leunig M, Berk DA, Jain RK: Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 1993, 45:269-289
31. Atherton A, Born GVR.: Quantitative investigations of the adhesiveness of circulating polymorphonuclear leukocytes to blood vessel walls J Physiol 1972, 222: 447-474
32. Schmid-Schoenbein GW, Zweifach BW, Kovalcheck S: The application of stereological principles to morphometry of the microcirculation in different tissues. Microvasc Res 1977, 14:303-317
33. Melder RJ, Munn LL, Yamada S, Ohkubo C, Jain RK: Selectin and integrin mediated T lymphocyte rolling and arrest on TNFα-activated endothelium is augmented by erythrocytes. Biophys J 1995, 69:2131-2138
34. Collins PD, Connolly DT, Williams TJ: Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 1993, 109:195-199
35. Folkman J, Szabo S, Shing Y: Sucralfate affinity for fibroblast growth factor. J Cell Biol 1990, 111:223a
36. Hu DE, Fan T-PD: Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br J Pharmacol 1995, 114:262-268
37. Dudar TE, Jain RK: Microcirculatory flow changes during tissue growth. Microvasc Res 1983, 25:1-21
38. Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, Gross JF: Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 1989, 17:91-99
39. Endrich B, Intaglietta M, Reinhold HS, Gross JF: Hemodynamic characteristics in microcirculatory blood channels during early tumor growth. Cancer Res 1979, 39:17-23
40. Endrich B, Hammersen F, Goetz A, Messmer K: Microcirculatory blood flow, capillary morphology, and local oxygen pressure of the hamster amelanotic melanoma A-Mel-3. J Natl Cancer Inst 1982, 68:475-485
41. Clough G, Noor N, Smaje LH: Polymorphonuclear leukocyte (PMN) interaction with the walls of developing blood vessels. Prog Appl Microcirc 1987, 12:195-199
42. Ohkubo C, Bigos D, Jain RK: Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res 1991, 51:1561-1563
43. Wu NZ, Klitzman B, Dodge R, Dewhirst MW: Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res 1992, 52:4265-4268
44. Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK: TNF-α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 1995, 55:4824-4829
45. Dellian M, Abels C, Kuhnle GEH, Goetz AE: Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue. Br J Cancer 1995, 72:1125-1130
46. Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of balb/c mice. Am J Physiol 1994, 267:H1320-H1328
47. Nguyen M, Strubel NA, Bischoff J: A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 1993, 365:267-269
48. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994, 264:569-571
49. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms fo E-selectin and vascular cell adhesion molecules-1. Nature 1995, 376:517-519
50. Hynes RO: Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992, 69:11-25
51. Loftus JC, Smith JW, Ginsberg MH: Integrin-mediated cell adhesion: the extracellular face. J Biol Chem 1994, 269:25235-25238
52. Jain RK, Koenig GC, Dellian M, Fukumura D, Munn LL, Melder RJ: Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev 1996 (in press)
53. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108: 2369-2379
54. Gerlowski LE, Jain RK: Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986, 31:288-305
55. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK: Vascular permeability in a human tumor xenograft: molecular size dependence and cut-off size. Cancer Res 1995, 55:3752-3756
56. Wilting J, Christ B, Bokeloh M, Weich H: In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993, 274: 163-172
57. Dvorak HF: Tumors, wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315:1650-1659
58. Sprugel KH, McPherson JM, Clowes AW, Ross R: Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 1987, 129:601-613
59. Broadwell RD, Baker BJ, Ebert PS, Hickey WF: Allografts of CNS tissue possess a blood brain barrier. III. Neuropathological, methodological, and immunological considerations. Microscopy Res Tech 1994, 27: 471-494
60. Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995, 87:1588-1592